DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on ...
Zacks.com on MSN
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
In the latest trading session, DaVita HealthCare (DVA) closed at $236.97, marking a +1.26% move from the previous day. This ...
Unfortunately, DaVita’s growth algorithm has become more challenging. After decades of expansion, total dialysis treatment ...
Shares of DaVita Inc. DVA shed 1.21% to $234.10 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.19% to 7,443.28 and Dow Jones ...
Zacks Investment Research on MSN
DaVita HealthCare (DVA) rises as market takes a dip: Key facts
DaVita HealthCare (DVA) ended the recent trading session at $234.01, demonstrating a +1.04% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 0.
DaVita is one of the largest kidney care providers in the world, with both in-center and home dialysis options. While DaVita isn't a traditional health system, the organization does operate inpatient ...
DaVita Novi will reopen July 2 after an investigation into the death of a patient and sicknesses of several others treated at the center.
Colorado-based kidney-care company DaVita has agreed to pay about $34.5 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce referrals to DaVita Rx, a ...
UnitedHealth strikes a $4.9 billion deal to acquire the DaVita Medical Group unit from kidney dialysis firm DaVita in an all-cash transaction. Last month, DMG posted a $5 million operating loss in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results